Drug Trial Radar · NCT07408232
A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Mar 10, 2026
Primary completion
Nov 1, 2028
Study completion Nov 1, 2028
Sponsor
- Lead sponsor
- Octant, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This integrated Ph1/2 clinical study is to assess the safety, tolerability and pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of OCT-980 in healthy volunteers and participants with RHO-adRP.
Conditions
- Retinitis Pigmentosa
Interventions
Phase 1b/2: Cohort 1 - OCT-980 TabletDrug
OCT-980 tablets administered orally once daily at dose levels specified in the protocol
Phase 1b/2: Cohort 2 - OCT-980 TabletDrug
OCT-980 tablets administered orally once daily at dose levels specified in the protocol
Phase 1b/2: Cohort 3 - OCT-980 TabletDrug
OCT-980 tablets administered orally once daily at dose levels specified in the protocol
Phase 1b/2: Cohort 4 - OCT-980 TabletDrug
OCT-980 tablets administered orally once daily at dose levels specified in the protocol
Phase 1b/2: Cohort 5 - OCT-980 TabletDrug
OCT-980 tablets administered orally once daily at dose levels specified in the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability of multiple doses (Phase 1b/2) of OCT-980 in participants with a genetic diagnosis of RHO-adRP.Time frame: Time Frame: From Baseline to Week 60 (Ph 1b/2)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Casey Eye Institute
Portland, Oregon · Recruiting
Retina Foundation of the Southwest
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.